Press Releases


Latest News


Adamas Pharmaceuticals Provides Review of 2015 and Projected Future Milestones
Jan 12, 2016 | General Releases

Adamas Announces Pricing of Public Offering of Common Stock
Jan 7, 2016 | General Releases

Adamas Announces Proposed Public Offering of Common Stock
Jan 5, 2016 | General Releases

Adamas Announces Positive Top-Line Phase 3 Results of ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease
Dec 23, 2015 | General Releases

Adamas to Host Conference Call and Webcast to Provide Company Update
Dec 22, 2015 | General Releases

Adamas Completes Enrollment of Its Phase 3 EASE LID 3 Study Evaluating ADS-5102 for Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Dec 14, 2015 | General Releases

Adamas Pharmaceuticals to Present at the 27th Annual Piper Jaffray Healthcare Conference
Nov 17, 2015 | General Releases

Adamas Reports Third Quarter 2015 Financial Results
Nov 12, 2015 | Financial Releases

Adamas Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare Conference
Oct 27, 2015 | General Releases

Adamas Presents Nonclinical Findings Supporting the Potential Use of ADS-5102 for the Treatment of Multiple Sclerosis Gait
Oct 12, 2015 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11 12